Integrated Analysis of Multiple Gene Expression Profiling Datasets Revealed Novel Gene Signatures and Molecular Markers in Nasopharyngeal Carcinoma

Abstract

Purpose: To identify the novel gene signatures and molecular markers of nasopharyngeal carcinoma (NPC) by integrated bioinformatics analysis of multiple gene expression profiling datasets.Experimental Design: Seven published gene expression profiling studies and one of our unpublished works were reanalyzed to identify the common significantly dysregulated (CSD) genes in NPC. Overrepresentation analysis of cytogenetic bands, Gene Ontology (GO) categories, pathways were used to explore CSD genes functionally associated with carcinogenesis. The protein expressions of selected CSD genes were examined by immunohistochemistry on tissue microarrays, and the correlations of their expressions with clinical outcomes were evaluated.Results: Using the criteria (genes reported deregulated in more than one study), a total of 962 genes were identified as the CSD genes in NPC. Four upregulated (BUB1B, CCND2, CENPF, and MAD2L1) and two downregulated (LTF and SLPI) genes were markedly reported in six studies. The enrichments of chromosome aberrations were 2q23, 2q31, 7p15, 12q15, 12q22, 18q11, and 18q12 in upregulated genes and 14q32 and 16q13 in downregulated genes. The activated GO categories and pathways related to proliferation, adhesion, invasion, and downregulated immune response had been functionally associated with NPC. SLPI significantly downregulated in nasopharyngeal adenocarcinoma. Furthermore, the high expression of BUB1B or CENPF was associated with poor overall survival of patients.Conclusion: It was first clearly identified the dysregulated expression of BUB1B and SLPI in NPC tissues. Impact: Further studies of the CSD genes as gene signatures and molecular markers of NPC might improve the understanding of the disease and identify new therapeutic targets. Cancer Epidemiol Biomarkers Prev; 21(1); 166-75. Ó2011 AACR.

miR-429 Identified by Dynamic Transcriptome Analysis Is a New Candidate Biomarker for Colorectal Cancer Prognosis

“…The biology of cancer, especially omic-base data, suggests a network-based structure in which gene products can be interrelated in a network fashion. The genome-wide integration of miRNA with gene expression data in relation to miRNA-target gene interactions is an innovative way to picture the aberrant landscape of posttranscriptional regulation (Cui et al, 2006;Huang et al, 2012;Li et al, 2011;Luo et al, 2012). In this project, we combined two types of data from the same group of patients to construct a miRNA-target genes network and to uncover candidate miRNAs.…”

Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients

“…Moreover, no NPC subtype emerged on the basis of differential protein expression, which could point towards potential therapeutic targets. Following the breast cancer paradigm [74], the reported gene-profiling approaches in NPC end up to different gene sets [75,76], calling once again for the need of bioinformatics implementation to data interpretation.…”

Integrative Gene Set Analysis: Application to Platinum Pharmacogenomics

“…Expression of CENPF has been found to be associated with methotrexate response in the treatment of acute lymphoblastic leukemia (Sorich et al, 2008), head and neck squamous cell carcinomas (de la Guardia et al, 2001), astrocytoma progression (van den Boom et al, 2003), and survival following breast cancer (Campone et al, 2008;Huang et al, 2012). Future research is needed to determine the precise role of LMNB1 and CENPF in response to CDDP and other platinum agents, such as carboplatin.…”